1 414-918-9890

7th Immunotherapy of Cancer Conference

The ITOC7 Scientific Programme is now online!

Welcome to the seventh edition of the Immunotherapy of Cancer Conference (ITOC7), the premier annual meeting for education, scientific exchange and networking within cancer immunotherapy.
April 2 - 4, 2020 | Munich, Germany

The scientific programme with an international faculty will focus on an update of many topics such as “Emerging Concepts/New Agents”, “Tumor microenviroment”, “Vaccine therapy”, “Precision Medicine meets Immunotherapy (Immuno-Monitoring)” and “Combination Therapy”.
For this congress, ITOC7, we have given consideration to a great number of ideas proposed by participants of former congresses, as well as by members of the Scientific Board. For example, by including the new session entitled “Microbiome and immunotherapy”, we have given consideration to the increasing significance of the microbiome in immunotherapy.

Also the new “Pro & Contra Session” at which this time the focus is to be on the topic “Blinatumomab vs anti-CD19 CAR T cells” is intended to facilitate decision-making for doctors engaged in oncological work in everyday hospital situations on the basis of facts which are scientifically well substantiated.

View the Program

Sign Up Now
Register now and benefit from the early bird fee until December 1, 2019

Submit Now
Submit your abstract until December 1, 2019 to present your work at ITOC7


Cooperation Partners